Detalhe da pesquisa
1.
CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia.
Blood
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776511
2.
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Blood
; 143(22): 2227-2244, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493484
3.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
4.
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Blood
; 2024 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687605
5.
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.
Cell
; 147(2): 306-19, 2011 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22000011
6.
Current European flood-rich period exceptional compared with past 500 years.
Nature
; 583(7817): 560-566, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699397
7.
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Blood
; 141(19): 2372-2389, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580665
8.
Mast Cell Activation Syndrome: current understanding and research needs.
J Allergy Clin Immunol
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38851398
9.
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
Allergy
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651829
10.
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
Am J Hematol
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822666
11.
Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
Curr Allergy Asthma Rep
; 24(3): 133-141, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308674
12.
Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis.
J Allergy Clin Immunol
; 152(4): 1019-1024, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423405
13.
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.
J Allergy Clin Immunol
; 151(1): 202-211, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953001
14.
Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patients.
Cancer
; 129(21): 3466-3475, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470252
15.
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.
Blood
; 138(23): 2347-2359, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320169
16.
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Blood
; 137(2): 238-247, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777817
17.
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.
Blood
; 137(15): 2070-2084, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512435
18.
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Allergy
; 78(1): 47-59, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207764
19.
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
Ann Hematol
; 102(8): 2077-2085, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012462
20.
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.
Eur J Haematol
; 110(1): 67-76, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193973